drugset / Trial / NCT05536882

MC RCT - BPO vs Adapalene

NCT05536882 ↗

Phase 3 Withdrawn University of Oklahoma
RandomizedParallel-groupOpen-labelTreatment

Summary

Non-blinded randomized controlled trial comparing efficacy of topical benzoyl peroxide 10% (vehicle choice per patient preference: e.g. gel, cream, lotion, wash) to topical adapalene 0.1% gel in the treatment of molluscum contagiosum in children aged 1 year old to 14 years old. * Two treatment wings: topical benzoyl peroxide 10% (vehicle choice per patient preference) applied 1-2x daily as tolerated vs adapalene 0.1% gel applied 1-2x daily as tolerated. * Primary outcome: Complete clearance at 12wks (defined as lack of identifiable papular molluscum contagiosum lesions on physical exam) * Secondary outcomes: % change in lesion count at 12wks.

Timeline

Start
2022-05-18
Primary completion
2023-10-09
Completion
2023-10-09

Outcome

Outcome not reported

Stopped: “The original PI left the institution prior to final IRB approval and the remaining study team did not have the resources to continue.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adapalene Other / unclassified 0.1 % Topical
Subject Benzoyl Peroxide Other / unclassified 10 % Topical

Indications